Evidence map›Paper›PMID 42101088›Full record

ArticleMicrobiologyOpen2026

An Economical Bioprocess for Lipopeptide Production From Bacillus subtilis.

Derya Maral-Gül, Zülal Günay, Baran Mis, Rengin Eltem

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Derya Maral-GülDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Bornova, Izmir, Turkey.ORCID 0000-0002-6540-639X
Zülal GünayDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Bornova, Izmir, Turkey.ORCID 0000-0003-3893-9876
Baran MisDepartment of Bioengineering, Faculty of Engineering, Ege University, Bornova, Izmir, Turkey.
Rengin EltemDepartment of Bioengineering, Faculty of Engineering, Ege University, Bornova, Izmir, Turkey.ORCID 0000-0002-0642-7676

Funding

This study is supported by the Ege University Scientific Research Projects Coordination Unit under Project Number FDK-2019-20159.
6 · The paper itself

Abstract

Phytopathogenic fungi such as Fusarium solani (F. solani), Rhizoctonia solani (R. solani), and Botrytis cinerea (B. cinerea) cause plant diseases, leading to significant yield losses. Lipopeptides (LPs), secondary metabolites produced by Bacillus strains, exhibit antifungal properties against these pathogens. In this study, the LP production potential of Bacillus isolates was investigated, and the best-performing Bacillus sp. was selected for the optimization of the production medium and parameters. Hemolytic activities of Bacillus isolates were screened using blood agar, revealing that all 69 isolates exhibited hemolytic activity. The isolates were cultivated in Lysogeny Broth (LB) medium, and LP extractions were performed. The antifungal activity of LP extracts against F. solani, R. solani, and B. cinerea was assessed using the agar well diffusion method. The iturin and surfactin content of LP extracts was analyzed by quadrupole time-of-flight mass spectrometry. Five Bacillus sp. with high LP production potential were selected, and their cell growth was examined. Among them, Bacillus subtilis 4-Ka-22 demonstrated the highest cell growth. The cost-effective optimized production medium was determined as 0.1% molasses, 1% soybean meal, 0.5% CaCl

Indexed as

Antifungal AgentsBacillus subtilisLipopeptidesBiosurfactantsBotrytisCulture MediaFusariumPeptides, CyclicRhizoctoniaAntifungal AgentsCulture MediaLipopeptidesPeptides, Cyclicantifungal effectBacillus subtilislipopeptidproduction optimizationRSM

Identifiers

PMID42101088
PMCPMC13154768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.